Efficacy of 3‐Hydroxy‐3‐Methylglutaryl Coenzyme A Reductase Inhibitors for Prevention of Stroke

Stephen Warshafsky,David Packard,Stephen Marks,Neeraj Sachdeva,Dawn Terashita,Gabriel Kaufman,Koky Sang,Albert J. DeLuca,Stephen J. Peterson,William H. Frishman

Efficacy of 3‐Hydroxy‐3‐Methylglutaryl Coenzyme A Reductase Inhibitors for Prevention of Stroke

1999

Stephen Warshafsky
David Packard
Stephen Marks
Neeraj Sachdeva
Dawn Terashita
Gabriel Kaufman
Koky Sang
Albert J. DeLuca
Stephen J. Peterson
William H. Frishman

OBJECTIVE: To determine if 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) are effective in preventing fatal and nonfatal strokes in patients at increased risk of coronary artery disease.

Keywords:

Family medicine
Reductase
HMG-CoA reductase
Coronary artery disease
Stroke
Hydroxymethylglutaryl-CoA reductase
Cholesterol
Endocrinology
Diabetes mellitus
Medicine
Coenzyme A
Pharmacology
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

114

References

Citations